1 - 15 of 49 Results Clear All
Benoit Bruneau and Katie Pollard study DNA folding to identify the genetic causes of congenital heart disease
Grants News Release Congenital Heart Disease Cardiovascular Disease Data Science and Biotechnology Bruneau Lab Pollard Lab
abc News—Gladstone President Deepak Srivastava, MD, comments on the fact that the experimental treatments President Trump received for COVID-19 were tested on cells that were derived from fetal tissue decades ago, and expresses concern that the Trump administration's current ban on the use of fetal tissue for research could slow efforts to curb the pandemic.
Gladstone Experts COVID-19 Cardiovascular Disease Srivastava Lab
The New York Times—The experimental drugs used to treat President Trump for COVID-19 were developed with the help of a human cell line derived from a fetus aborted decades ago. Gladstone President Deepak Srivastava, MD, and Senior Investigator Warner Greene, MD, PhD, comment on the ethics of accepting this treatment while also banning research using newly derived fetal cells, in the process thwarting the development of life-saving treatments for other conditions.
Gladstone Experts COVID-19 Cardiovascular Disease Center for HIV Cure Research Greene Lab Srivastava Lab
San Francisco Business Times—As Scribe Therapeutics Inc., the latest company founded by Senior Investigator Jennifer Doudna, PhD, announced that it landed a deal with Biogen Inc., Gladstone President Deepak Srivastava, MD, commented on the importance of CRISPR-based biotech companies for medicine and agriculture and on Doudna’s drive as a scientist.
Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Doudna Lab Srivastava Lab CRISPR/Gene Editing
The Guardian—Recent work from Senior Investigators Todd McDevitt, PhD, and Bruce Conklin, MD, documenting the damaging effect of SARS-CoV-2 on heart cells is mentioned in a detailed review of the long-term impact of COVID-19 on patients’ hearts.
Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Conklin Lab McDevitt Lab
Technology Network—Senior Investigator Bruce Conklin, MD, explains how SARS-CoV-2 damages heart cells and how heart cells grown in the lab could be used to screen for drugs against infection by the novel coronavirus.
Gladstone Experts COVID-19 Cardiovascular Disease Conklin Lab
Ken Nakamura and Todd McDevitt will study how to boost cells’ energy and how the strategy can best treat disease
Grants Cardiovascular Disease Neurological Disease McDevitt Lab Nakamura Lab
The Wall Street Journal—Senior Investigator Todd McDevitt, PHD, comments on the damage SARS-CoV-2 can inflict on heart cells, which he and Senior Investigator Bruce Conklin, MD, recently reported in an article deposited on bioRxiv.
Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Conklin Lab McDevitt Lab
The New Indian Express—The New Indian Express integrates the recent findings of Senior Investigators Todd McDevitt, PhD, and Bruce Conklin, MD, in an opinion piece about the effects of COVID-19 on the heart.
Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Conklin Lab McDevitt Lab
Wired—In an article about the potential dangers of strenuous exercise for people who have been infected with SARS-CoV-2, Senior Investigator Bruce Conklin, MD, is quoted for likening to "carnage" the damage the virus can inflict on heart cells. Conklin and Senior Investigator Todd McDevitt, PhD, recently reported their observations of cardiac cells from deceased COVID-19 patients or grown in the lab in BioRxiv.
Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Conklin Lab McDevitt Lab
The Times of India—The Times of India reports the recent discovery by Senior Investigators Todd McDevitt, PhD, and Bruce Conklin, MD, that SARS-CoV-2 can inflict severe damage to heart cells, and puts it in the context of several examples of cardiovascular failure in patients recovering from COVID-19 in India.
Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Conklin Lab McDevitt Lab
The New Republic—Senior investigator Todd McDevitt, PhD, explains how his recent discovery that SARS-CoV-2 inflicts severe damage on heart cells could explain why some people experience symptoms of heart malfunction months after they recover from COVID-19. McDevitt stresses that COVID-19 is not just a respiratory disease, and could instead lead to permanent damage to various organs, even in young people.
Gladstone Experts COVID-19 Cardiovascular Disease McDevitt Lab
Yahoo! News—Some individuals who survive the initial bout with COVID-19 experience heart damage weeks or months later. Gladstone Investigator Todd McDevitt explains how his recent research shows that SARS-CoV-2 can devastate heart muscle cells, which could have long-term consequences for heart function.
Gladstone Experts COVID-19 Cardiovascular Disease McDevitt Lab
Live Science—Senior Investigators Todd McDevitt, PhD, and Bruce Conklin, MD, comment on their recent discovery that SARS-CoV-2 infects and destroys heart muscle cells grown in the lab and may do so in the hearts of COVID-19 patients as well.
Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Conklin Lab McDevitt Lab
ABC7 News—As sports teams and colleges consider restarting the athletics season, Senior Investigator Todd McDevitt, PhD, and Gladstone President and Cardiologist Deepak Srivastava, MD, express concern that damage to the heart caused by SARS-CoV-2 infection could put athletes at risk for serious heart problems even if they only experienced mild COVID-19 symptoms.
Gladstone Experts COVID-19 Cardiovascular Disease McDevitt Lab Srivastava Lab